We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals

14 hedge funds and large institutions have $9.5M invested in Corbus Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9.68% more ownership

Funds ownership: 0% → 9.68% (+9.7%)

Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CRBP Hedge Fund Activity: Q2 2015 in Review

14 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q2 2015, worth a combined $9.5M.

Buyers outnumbered sellers: 14 funds opened new CRBP positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Knoll Capital Management, opening a new position worth an estimated $5.87M.

  • 14 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $9.5M of Corbus Pharmaceuticals stock for Q2 2015.
  • 14 funds opened new Corbus Pharmaceuticals positions in Q2 2015 and 0 closed out, a net change of +14 holders.
  • The largest Corbus Pharmaceuticals buyer in Q2 2015 was Knoll Capital Management, an estimated $5.87M added.

Based on aggregated 13F filings for Q2 2015.